Medigene AG (WBO:MDG1) EPS (Basic) : €-0.63 (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medigene AG EPS (Basic)?

Medigene AG's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was €-0.36. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.63.

Medigene AG's EPS (Diluted) for the six months ended in Dec. 2023 was €-0.36. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.63.

Medigene AG's EPS without NRI for the six months ended in Dec. 2023 was €-0.36. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -0.63.

During the past 3 years, the average EPS without NRI Growth Rate was 17.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Medigene AG's highest 3-Year average EPS without NRI Growth Rate was 32.40% per year. The lowest was -36.60% per year. And the median was 16.60% per year.

Medigene AG EPS (Basic) Historical Data

The historical data trend for Medigene AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG EPS (Basic) Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.77

-1.12

-0.39

-0.32

-0.63

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EPS (Basic)	Get a 7-Day Free Trial															-0.17	0.54	-0.86	-0.27	-0.36

Medigene AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Medigene AG's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-16.177	-	0)	/	25.866
	=	-0.63

Medigene AG's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-9.207	-	0)	/	25.866
	=	-0.36

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.63

Medigene AG (WBO:MDG1) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Medigene AG EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Medigene AG's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (WBO:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Germany

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (WBO:MDG1) Headlines

No Headlines